These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 26945496)

  • 1. Natural history of Hymenoptera venom allergy in children not treated with immunotherapy.
    Lange J; Cichocka-Jarosz E; Marczak H; Krauze A; Tarczoń I; Świebocka E; Lis G; Brzyski P; Nowak-Węgrzyn A
    Ann Allergy Asthma Immunol; 2016 Mar; 116(3):225-9. PubMed ID: 26945496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hymenoptera venom immunotherapy and field stings.
    Lang R; Hawranek T
    J Investig Allergol Clin Immunol; 2006; 16(4):224-31. PubMed ID: 16889279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-dependent sting recurrence and outcome in immunotherapy-treated children with anaphylaxis to Hymenoptera venom.
    Stritzke AI; Eng PA
    Clin Exp Allergy; 2013 Aug; 43(8):950-5. PubMed ID: 23889248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of Hymenoptera venom allergy.
    Biló BM; Rueff F; Mosbech H; Bonifazi F; Oude-Elberink JN;
    Allergy; 2005 Nov; 60(11):1339-49. PubMed ID: 16197464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology, diagnosis, and treatment of Hymenoptera venom allergy in mastocytosis patients.
    Niedoszytko M; Bonadonna P; Oude Elberink JN; Golden DB
    Immunol Allergy Clin North Am; 2014 May; 34(2):365-81. PubMed ID: 24745680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rush hymenoptera venom immunotherapy is efficacious and safe.
    Pasaoglu G; Sin BA; Misirligil Z
    J Investig Allergol Clin Immunol; 2006; 16(4):232-8. PubMed ID: 16889280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical aspects of hymenoptera venom allergy and venom immunotherapy.
    Bilò MB; Tontini C; Martini M; Corsi A; Agolini S; Antonicelli L
    Eur Ann Allergy Clin Immunol; 2019 Nov; 51(6):244-258. PubMed ID: 31594296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitization to Hymenoptera venoms is common, but systemic sting reactions are rare.
    Sturm GJ; Kranzelbinder B; Schuster C; Sturm EM; Bokanovic D; Vollmann J; Crailsheim K; Hemmer W; Aberer W
    J Allergy Clin Immunol; 2014 Jun; 133(6):1635-43.e1. PubMed ID: 24365141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. When can immunotherapy for insect sting allergy be stopped?
    Müller UR; Ring J
    J Allergy Clin Immunol Pract; 2015; 3(3):324-8; quiz 329-30. PubMed ID: 25956311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basophil sensitivity in patients not responding to venom immunotherapy.
    Peternelj A; Silar M; Erzen R; Kosnik M; Korosec P
    Int Arch Allergy Immunol; 2008; 146(3):248-54. PubMed ID: 18270492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaphylactic Reactions After Discontinuation of Hymenoptera Venom Immunotherapy: A Clonal Mast Cell Disorder Should Be Suspected.
    Bonadonna P; Zanotti R; Pagani M; Bonifacio M; Scaffidi L; Olivieri E; Franchini M; Reccardini F; Costantino MT; Roncallo C; Mauro M; Boni E; Rizzini FL; Bilò MB; Marcarelli AR; Passalacqua G
    J Allergy Clin Immunol Pract; 2018; 6(4):1368-1372. PubMed ID: 29258788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of hymenoptera venom immunotherapy.
    Kayikci H; Bostan OC; Tuncay G; Cihanbeylerden M; Damadoglu E; Karakaya G; Kalyoncu AF
    Allergy Asthma Proc; 2024 Jul; 45(4):268-275. PubMed ID: 38982604
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety profile of hymenoptera venom immunotherapy (VIT) in monosensitized patients: lack of new sensitization to nontreated insect venom.
    Spoerl D; Bircher AJ; Scherer K
    J Investig Allergol Clin Immunol; 2011; 21(1):22-7. PubMed ID: 21370719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insect sting allergy with negative venom skin test responses.
    Golden DB; Kagey-Sobotka A; Norman PS; Hamilton RG; Lichtenstein LM
    J Allergy Clin Immunol; 2001 May; 107(5):897-901. PubMed ID: 11344359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of re-sting reactions in children with moderate to severe venom hypersensitivity.
    Ertoy Karagol HI; Bakirtas A; Yilmaz O; Topal E; Arga M; Demirsoy MS; Turktas I
    Eur J Pediatr; 2015 Jul; 174(7):891-6. PubMed ID: 25563216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venom immunotherapy in patients with allergic reactions to insect stings.
    Incorvaia C; Mauro M; Gritti BL; Makri E; Ridolo E
    Expert Rev Clin Immunol; 2018 Jan; 14(1):53-59. PubMed ID: 29202591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of venom immunotherapy on serum level of CCL5/RANTES in patients with Hymenoptera venom allergy.
    Gawlik R; Glück J; Jawor B; Rogala B
    Immunopharmacol Immunotoxicol; 2015; 37(4):375-9. PubMed ID: 26181651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hymenoptera Venom Allergy: Re-Sting reactions.
    Mesquita AM; Carneiro-Leão L; Amaral L; Coimbra A
    Eur Ann Allergy Clin Immunol; 2021 Mar; 53(2):94-96. PubMed ID: 32548996
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of Hymenoptera venom allergy: an update.
    Pesek RD; Lockey RF
    Curr Opin Allergy Clin Immunol; 2014 Aug; 14(4):340-6. PubMed ID: 24887986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological differences between insect venom-allergic patients with and without immunotherapy and asymptomatically sensitized subjects.
    Arzt L; Bokanovic D; Schrautzer C; Laipold K; Möbs C; Pfützner W; Herzog SA; Vollmann J; Reider N; Bohle B; Aberer W; Sturm GJ
    Allergy; 2018 Jun; 73(6):1223-1231. PubMed ID: 29171032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.